Efficacy and safety of treatment with sofosbuvir/velpatasvir in patients aged 6–18 years with chronic hepatitis C—Results of the PANDAA‐PED study.

Autor: Pokorska‐Śpiewak, Maria1,2 (AUTHOR) maria.pokorska‐spiewak@wum.edu.pl, Talarek, Ewa1,2 (AUTHOR), Aniszewska, Małgorzata1,2 (AUTHOR), Pluta, Magdalena1,2 (AUTHOR), Dobrzeniecka, Anna2 (AUTHOR), Marczyńska, Magdalena1,2 (AUTHOR), Indolfi, Giuseppe3 (AUTHOR)
Zdroj: Liver International. Sep2023, Vol. 43 Issue 9, p1871-1878. 8p. 1 Diagram, 3 Charts, 1 Graph.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje